Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand.
The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals.
The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).
The diversification into TMP is beneficial as SMX and TMP a ...re used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO.
In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.
The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale to
pilot scale in pilot plant and finally manufacturing at the commercial scale in manufacturing facilities, which are in line with cGMP requirements. A combination of chemistry knowledge, with engineering strengths, along with good analytical backup enables Godavari Drugs to develop, scale, up and manufacture products right from laboratory to commercial scale.
1. Can I buy Godavari Drugs Ltd from PL Capital? ›
Yes, you can invest in Godavari Drugs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Godavari Drugs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Godavari Drugs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Godavari Drugs Ltd pay dividends? ›
Godavari Drugs Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Godavari Drugs Ltd ? ›
As of
14-01-2026 the share price for Godavari Drugs Ltd. is 88.22 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Godavari Drugs Ltd ? ›
The 52-week high and low of Godavari Drugs Ltd share price is ₹ 69.7 - ₹ 118.95 as of
14-01-2026 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
